INMUNE BIO INC
INMB·45782T105·US·Common Stock·Healthcare - Biotechnology-13D/G
INMB (INMUNE BIO INC) is held by 56 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.3M), VANGUARD CAPITAL MANAGEMENT LLC ($776,327), GEODE CAPITAL MANAGEMENT, LLC ($559,464). Net institutional sentiment: Mixed.
56
Holders
Avg rating(15 Elite)
$5.6M
Total Value
52% (62)
Fund Consensus
26 buying - 24 selling
Who's Trading
ActivistHIHighbridge Capital Management, LLC5.2%Aug 14, 2025
ActivistCICVI Investments, Inc.4.9%Aug 14, 2025
ActivistPPPraetorian PR LLC2.9%Aug 14, 2025
13F: Insider & Congress:
Showing 1-20 of 62
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer